ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
24.11
-2.87 (-10.64%)
At close: Oct 29, 2025, 4:00 PM EDT
24.52
+0.41 (1.70%)
After-hours: Oct 29, 2025, 7:13 PM EDT
ClearPoint Neuro Employees
ClearPoint Neuro had 115 employees as of December 31, 2024. The number of employees increased by 8 or 7.48% compared to the previous year.
Employees
115
Change (1Y)
8
Growth (1Y)
7.48%
Revenue / Employee
$292,113
Profits / Employee
-$193,243
Market Cap
685.39M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 115 | 8 | 7.48% |
| Dec 31, 2023 | 107 | -1 | -0.93% |
| Dec 31, 2022 | 108 | 28 | 35.00% |
| Dec 31, 2021 | 80 | 13 | 19.40% |
| Dec 31, 2020 | 67 | 18 | 36.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CLPT News
- 22 days ago - ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - Accesswire
- 23 days ago - ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - Accesswire
- 27 days ago - ClearPoint Neuro: AMT-130 Highlights A Bright Future - Seeking Alpha
- 4 weeks ago - ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - Accesswire
- 4 weeks ago - ClearPoint Neuro: Selling The Tools For Brain Therapies - Seeking Alpha
- 4 weeks ago - ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer - Accesswire
- 7 weeks ago - ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners - Accesswire
- 2 months ago - ClearPoint Neuro: Biopharma Momentum Continues To Build - Seeking Alpha